Does Atrial Fibrillation (Afib) Impact The Rate Of 90 Days Modified Rankin Scale (mRS) In Patients Who Received Intravenous Thrombolytic (IVT) Before Endovascular Treatment (EVT)? Results From A Large Health System In Six Western States Of The US

Authors

R Bavarsad Shahripour
Alyx Lesko, Providence Brain and Spine InstituteFollow
See all authors in comments

Document Type

Presentation

Publication Date

8-1-2023

Keywords

oregon; psvmc; portland

Clinical Institute

Neurosciences (Brain & Spine)

Clinical Institute

Cardiovascular (Heart)

Specialty

Neurosciences

Specialty

Critical Care Medicine

Specialty

Cardiology

Comments

Bavarsad Shahripour, R. Marginean, H; Corless, L; Lowenkopf, T; Lesko, A; Guerrero, A; Singh, T; Loh, Y; Tarpley, J (2023, August). Does Atrial Fibrillation (Afib) Impact The Rate Of 90 Days Modified Rankin Scale (mRS) In Patients Who Received Intravenous Thrombolytic (IVT) Before Endovascular Treatment (EVT)? Results From A Large Health System In Six Western States Of The US. Poster Presented at the International Stroke Conference.

Recommended Citation

Bavarsad Shahripour, R; Lesko, Alyx; and See all authors in comments, "Does Atrial Fibrillation (Afib) Impact The Rate Of 90 Days Modified Rankin Scale (mRS) In Patients Who Received Intravenous Thrombolytic (IVT) Before Endovascular Treatment (EVT)? Results From A Large Health System In Six Western States Of The US" (2023). Articles, Abstracts, and Reports. 8062.
https://digitalcommons.providence.org/publications/8062